IVIRMA Global announces the departure of Professor Geeta Nargund

Professor Geeta Nargund steps down as Medical Director of CREATE Fertility and abc ivf. Dr Cesar Diaz joins as Chief Medical Officer for IVIRMA Northern Europe.

London, June 2025. IVIRMA Global, the world’s leading fertility group, today announces a leadership transition in its Northern European operations, with the departure of Professor Geeta Nargund, Founder and Medical Director of CREATE Fertility and abc ivf, and the appointment of Dr. Cesar Diaz as Chief Medical Officer for the region.

Professor Nargund established CREATE Fertility as the first dedicated Natural and Mild IVF clinic in Europe and brought affordable IVF to the UK for the very first time with abc ivf. Professor Nargund’s departure from CREATE Fertility after more than 20 years as Medical Director will allow her to focus on her commitments to research, improving women’s health and addressing wider health inequalities through her academic, NHS, charitable roles and  executive positions including Board Member of the Human Fertilisation & Embryology Authority, and Vice Chair of the British Red Cross.

Dr. Diaz’s appointment marks a new chapter in IVIRMA’s clinical leadership across the region, building on the foundation laid by Professor Nargund. As CMO, he will oversee medical strategy and clinical excellence across IVIRMA’s Northern European brands, including CREATE Fertility, abc ivf, Livio, IVI, Vitanova, and Carl von Linné.

With extensive international experience—including clinical leadership roles in Spain, the UK, and the Nordics—Dr. Diaz joins from the NHS in Scotland and brings deep expertise in patient-centered fertility care. He previously served as Medical Director of IVI London, part of the IVIRMA group.

While Professor Nargund will be stepping away from CREATE Fertility and abc ivf, IVIRMA Global remains committed to the principles she has long championed —such as continuing research on mild and natural IVF, promoting accessible, woman-centred fertility care, and addressing broader societal challenges like health inequalities and declining fertility rates.

Dan Annetts, Chief Executive of IVIRMA in Northern Europe said “I would like to thank Professor Geeta Nargund for her vision and leadership at CREATE Fertility and abc ivf over the years. Whilst we will miss her enormously, we are in great shape to build on her legacy. We are delighted that Dr Cesar Diaz will be taking on the role of CMO for Northern Europe. Under his medical leadership our patient care will go from strength to strength at CREATE Fertility, abc ivf and all our brands and clinics in the region.”

Dr Cesar Diaz said “I am honoured to take on the medical leadership of IVIRMA in Northern Europe. I am pleased to continue the important work for our patients at CREATE Fertility. I look forward to building on the strong foundation that has been established, and to building our clinical teams so we can continue to provide world-class fertility care.”

Professor Antonio Pellicer, Executive Chairman, IVIRMA Global said “I’ve had the opportunity to work alongside Geeta over many years and have always appreciated her commitment to patient care and her contribution to the development of Mild IVF. I thank her for her collaboration and wish her the very best as she steps back from day-to-day clinical work. I look forward to working with Dr. Cesar Diaz as he takes on this important leadership role.”

Professor Geeta Nargund said “I am proud of all that CREATE Fertility has achieved for generations of women in reducing the burden and side effects of fertility treatment, focusing on both the safety of women and success of treatment. Through abc ivf we introduced affordable IVF to the UK, providing care for those who otherwise would not have been able to access treatment. Our pioneering work has helped thousands of women and couples to CREATE families. I’m delighted that we have also been able to serve NHS patients across England.

“I want to thank our fantastic team for all their support and wish the company continued future success. I look forward to furthering my work championing better women’s health, improving gender parity in leadership and tackling health inequalities through advocacy, research and service.”   

For further information please contact our PR agency create@farrerkane.com

About IVIRMA Global
IVI was born in 1990 as the first medical institution in Spain fully specialised in human reproduction. Since then, it has helped more than 250,000 children to be born, thanks to the application of the latest technologies. In early 2017, IVI merged with RMA, becoming the largest assisted reproduction group in the world. It currently has more than 65 clinics in 9 countries and is a leader in reproductive medicine. IVIRMA acquired CREATE Fertility and abc ivf in 2021. Across Northern Europe IVIRMA operates under the CREATE Fertility, abc ivf and IVI brands in the UK; and the Livio, Carl von Linne and Vitanova brands in the Nordics.
ivirma.com

About Dr Cesar Diaz
Dr Cesar Diaz PhD, MD has developed his medical and scientific career between France, Spain, Sweden and the UK. He held the position of Medical Director of IVI London between 2017 and 2024 and served as former Associated editor of Human Reproduction and Human Reproduction Update. He currently works as a consultant in Reproductive Medicine at the Glasgow Royal Infirmary and Honorary Associate Professor at the University of Glasgow. His scientific career has been devoted to the field of fertility preservation, with special interest in ovarian cortex transplantation, uterus transplantation, follicular activation, poor response in IVF and reproductive surgery. He was part of the team achieving the first successful uterus transplantation in humans and the clinical lead of the Valencian Fertility Preservation Program, one of the largest fertility preservation programs in the world.

About CREATE Fertility
CREATE Fertility was founded by Professor Geeta Nargund and is now one of the largest providers of fertility treatments in the United Kingdom. A specialist in natural and mild approaches to IVF, which reduce the physical and emotional burden on women during treatment, the clinic provides over 4,000 treatments a year across their network. CREATE Fertility’s subsidiary abc ivf was set up to reduce financial burden of IVF and it offers affordable IVF care. Both CREATE Fertility and abc ivf are part of IVIRMA Global.
createfertility.co.uk

About Professor Geeta Nargund
Professor Nargund is a pioneer in the field of IVF, in particular leading clinical research in Mild & Natural IVF practices. She founded CREATE Fertility in the year 2000 and abc ivf (a subsidiary of CREATE Fertility) in 2017, developing both into leaders in Mild & Natural IVF and affordable IVF services respectively. In addition to her role as Founder and Medical Director of CREATE Fertility and abc ivf, Professor Nargund holds a number of other positions. She is a Board member, Human Fertilisation and Embryology Authority (HFEA), Lead Consultant at St George’s Hospital NHS Trust; President, International Society for Mild Approaches in Assisted Reproduction (ISMAAR) Vice Chair at the British Red Cross, Board Chair at The Pipeline, Hon Professor at Greater Manchester University, Director of Social Impact Enterprises, and Founder of CREATE Health Foundation.